RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Enzon Pharmaceuticals Stock

Enzon Pharmaceuticals ROA 2024

Enzon Pharmaceuticals ROA

0

Ticker

ENZN

ISIN

US2939041081

WKN

873997

In 2024, Enzon Pharmaceuticals's return on assets (ROA) was 0, a -106.52% increase from the -0.03 ROA in the previous year.

Enzon Pharmaceuticals Aktienanalyse

What does Enzon Pharmaceuticals do?

Enzon Pharmaceuticals Inc. is an American biotechnology company that has been active since 1981. They specialize in researching, developing, and marketing innovative medicines. The company operates primarily in the United States but is also internationally known and active. Enzon Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Enzon Pharmaceuticals's Return on Assets (ROA)

Enzon Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Enzon Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Enzon Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Enzon Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Enzon Pharmaceuticals stock

What is the Return on Assets (ROA) of Enzon Pharmaceuticals this year?

The Return on Assets (ROA) of Enzon Pharmaceuticals is 0 undefined this year.

What was the ROA of Enzon Pharmaceuticals compared to the previous year?

The ROA of Enzon Pharmaceuticals has increased by -106.52% compared to the previous year.

What consequences do high ROA have for investors of Enzon Pharmaceuticals?

A high ROA is advantageous for investors of Enzon Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Enzon Pharmaceuticals?

A low ROA can be unfavorable for investors of Enzon Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Enzon Pharmaceuticals affect the company?

An increase in ROA of Enzon Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Enzon Pharmaceuticals impact the company?

A reduction in the ROA of Enzon Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Enzon Pharmaceuticals?

Some factors that can influence the ROA of Enzon Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Enzon Pharmaceuticals important for investors?

The ROA of Enzon Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Enzon Pharmaceuticals take to improve ROA?

To improve ROA, Enzon Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Enzon Pharmaceuticals pay?

Over the past 12 months, Enzon Pharmaceuticals paid a dividend of 0.18 USD . This corresponds to a dividend yield of about 148.76 %. For the coming 12 months, Enzon Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Enzon Pharmaceuticals?

The current dividend yield of Enzon Pharmaceuticals is 148.76 %.

When does Enzon Pharmaceuticals pay dividends?

Enzon Pharmaceuticals pays a quarterly dividend. This is distributed in the months of January, October, March, October.

How secure is the dividend of Enzon Pharmaceuticals?

Enzon Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Enzon Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzon Pharmaceuticals located?

Enzon Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzon Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzon Pharmaceuticals from 10/15/2019 amounting to 0.12 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2019.

When did Enzon Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/15/2019.

What was the dividend of Enzon Pharmaceuticals in the year 2023?

In the year 2023, Enzon Pharmaceuticals distributed 0 USD as dividends.

In which currency does Enzon Pharmaceuticals pay out the dividend?

The dividends of Enzon Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Enzon Pharmaceuticals

Our stock analysis for Enzon Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzon Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.